Intrexon | Devedores Comerciais





Devedores Comerciais Alterar Data
Agenus USD 354K 53K 2025-03
Alaunos Therapeutics USD 2K 0 2025-06
Amgen USD 9.57B 1.08B 2025-12
Anika Therapeutics USD 21.99M 1.61M 2025-03
Arrowhead Research USD 218.87M 212.05M 2025-12
AstraZeneca USD 19.05B 1.49B 2025-12
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Gilead Sciences USD 4.91B 182M 2025-12
GlaxoSmithKline GBP 7.76B 545M 2025-12
Heron Therapeutics USD 67.04M 6.9M 2024-09
Incyte USD 1.02B 128.52M 2025-12
Intrexon USD 1.02M 559K 2024-06
Karyopharm Therapeutics USD 31.78M 6.82M 2024-09
Ligand Pharmaceuticals USD 58.1M 15.98M 2025-09
MacroGenics USD 69.23M 56.7M 2025-09
MannKind USD 38.37M 20.98M 2025-12
Merck USD 12.12B 596M 2025-09
Novartis USD 8.98B 192M 2025-09
Rigel Pharmaceuticals USD 28.9M 1.39M 2024-06
Roche Holding CHF 11.9B 460M 2025-12
Sangamo BioSciences USD 581K 110K 2024-06
Thermo Fisher Scientific USD 8.9B 11M 2025-12
Veracyte USD 44.66M 3.17M 2025-12
Xencor USD 29.3M 7.49M 2025-12


Intrexon Devedores Comerciais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2026.